💰

Biopharma SHAKTI Mission 2026

Biopharma SHAKTI Mission India 2026 — ₹10,000 Crore Biotech & Pharma Boost | birac.nic.in

2026 ✓Finance₹10,000 crore funding pool — grants, equity support, subsidised loans — for biotech startups, pharma MSMEs, vaccine manufacturers, genomics researchLaunched: 2026Updated: May 2026
2 min read
Reviewed by Sanket Ghogare, Editor · Last verified: 2 May 2026

Biopharma SHAKTI Mission 2026 — Quick Overview

Scheme NameBiopharma SHAKTI Mission India 2026 — ₹10,000 Crore Biotech & Pharma Boost | birac.nic.in
Launched ByGovernment of India
Launch Year2026
Benefit₹10,000 crore funding pool — grants, equity support, subsidised loans — for biotech startups, pharma MSMEs, vaccine manufacturers, genomics research
CategoryFinance
Last Verified2 May 2026
Official Portalhttps://birac.nic.in

What is Biopharma SHAKTI Mission 2026?

Biopharma SHAKTI (Synergizing Healthcare, Advancement, Knowledge, Technology and Innovation) is a new ₹10,000 crore flagship mission announced in Union Budget 2026-27 to position India as a global biotech and biopharma leader. The mission focuses on accelerating vaccine development, biologics manufacturing, biosimilar production, and genomics research. It builds on India's existing Biotechnology Industry Research Assistance Council (BIRAC) infrastructure and the Ayushman Bharat Health Infrastructure Mission. The scheme provides grants, equity support, and subsidised loans to biotech startups, MSMEs, and large pharma companies investing in next-generation biologics, mRNA platforms, cell and gene therapy, and precision medicine. India's pharma industry — valued at $65 billion — is already the world's 3rd largest by volume; Biopharma SHAKTI targets making it #1 by 2030.

Under this scheme, eligible beneficiaries receive ₹10,000 crore funding pool — grants, equity support, subsidised loans — for biotech startups, pharma MSMEs, vaccine manufacturers, genomics research. The scheme was launched in 2026 and is implemented by the Government of India.

🏴Hindi me Jankari

बायोफार्मा SHAKTI मिशन Union Budget 2026-27 का नया ₹10,000 करोड़ biotech & pharma scheme — vaccines, biologics, biosimilars, genomics, mRNA platforms। BIRAC + startups + MSMEs + large pharma को grants और subsidised loans। India को 2030 तक global pharma #1 बनाने का लक्ष्य।

₹10,000 करोड़ — grants, equity support, loans — biotech startups, pharma MSMEs, vaccine manufacturers, genomics, mRNA platforms

Benefits of Biopharma SHAKTI Mission 2026

₹10,000 crore funding pool — grants, equity support, subsidised loans — for biotech startups, pharma MSMEs, vaccine manufacturers, genomics research

Who is Eligible for Biopharma SHAKTI Mission 2026?

  • Biotech and biopharma companies registered in India
  • Startups registered with DPIIT (for startup-specific windows)
  • MSMEs in pharma / biotech sector
  • Research institutions and academic spin-offs with technology readiness
  • Large pharma companies for manufacturing scale-up in biosimilars, vaccines, cell & gene therapy
  • Applications through BIRAC's call-for-proposals under specific thematic windows

Documents Required for Biopharma SHAKTI Mission 2026

0/6 documents ready

How to Apply for Biopharma SHAKTI Mission 2026 Online?

  1. 1birac.nic.in → Funding → Open Calls → Biopharma SHAKTI Mission पर जाएं
  2. 2BIRAC portal पर company / startup registration करें
  3. 3Specific thematic call के अनुसार project proposal तैयार करें
  4. 4Online application submit करें — concept note → full proposal (2-stage)
  5. 5Peer review और BIRAC committee evaluation
  6. 6Grant / equity agreement signing → milestone-based disbursement
🏛️

Official Government Portal

Apply directly on the official government website. This is the only authorised portal — never pay anyone to apply on your behalf.

🔗Apply on birac.nic.in
Share on WhatsAppHelp others find this scheme

Frequently Asked Questions — Biopharma SHAKTI Mission 2026

₹10,000 crore pool se grants (up to ₹50 crore per project for R&D), equity support (BIRAC co-investment), and subsidised loans. Focus on: vaccines, biosimilars, mRNA, cell & gene therapy, precision medicine, genomics.

Related Finance Schemes

💰 Finance

PM Suraksha Bima Yojana — ₹2 Lakh Accident Insurance

PMSBY provides accidental death and disability insurance cover of ₹2 lakh for just ₹20 per year, renewable annually through bank auto-debit.

₹2 lakh accident cover for only ₹20/yearView Details →
💰 Finance
Updated Apr 2026

Atal Pension Yojana 2026 — Guaranteed ₹1,000–₹5,000 Monthly Pension | APY Registration

Atal Pension Yojana provides a guaranteed monthly pension of Rs.1,000 to Rs.5,000 after age 60 to unorganized sector workers. Over 7 crore subscribers enrolled. Small monthly contributions from age 18 ensure a dignified retirement income. Contributions also qualify for Section 80CCD(1B) tax deduction up to Rs.50,000.

Rs.1,000 to Rs.5,000 guaranteed monthly pension after age 60 + Section 80CCD(1B) tax deductionView Details →
💰 Finance
Updated May 2026

PM Jeevan Jyoti Bima Yojana 2026 — Rs.2 Lakh Life Insurance at Rs.436/Year

PM Jeevan Jyoti Bima Yojana (PMJJBY) is a government-backed renewable term life insurance scheme that offers Rs.2 lakh death cover for any cause at just Rs.436 per year. The premium is automatically debited from the subscriber's savings bank account every year between 25 May and 31 May. Launched in 2015 under Pradhan Mantri Jan Suraksha Yojana, the scheme is available to all bank account holders aged 18 to 50 years and is administered through partner public and private sector banks.

Rs.2 lakh life insurance cover for only Rs.436/yearView Details →
💰 Finance
🔥 PopularUpdated May 2026

PM Jan Dhan Yojana 2026 — Zero Balance Bank Account + ₹2 Lakh Insurance

Pradhan Mantri Jan Dhan Yojana (PMJDY) is India's largest financial inclusion scheme with 56+ crore accounts. Any Indian citizen can open a zero-balance savings account with free RuPay debit card, ₹2 lakh accident insurance, ₹30,000 life insurance, and ₹10,000 overdraft facility.

Zero balance account + ₹2L accident insurance + ₹10,000 overdraftView Details →
📢 Get free scheme updates!
Join Telegram